296 related articles for article (PubMed ID: 36675186)
1. Cross-Talk between N6-Methyladenosine and Their Related RNAs Defined a Signature and Confirmed m6A Regulators for Diagnosis of Endometriosis.
Wang X; Zhao X; Wang J; Wu H; Cheng Y; Guo Q; Liang T; Zhang G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675186
[TBL] [Abstract][Full Text] [Related]
2. METTL3-regulated m6A modification impairs the decidualization of endometrial stromal cells by regulating YTHDF2-mediated degradation of FOXO1 mRNA in endometriosis-related infertility.
Li X; Jin J; Long X; Weng R; Xiong W; Liang J; Liu J; Sun J; Cai X; Zhang L; Liu Y
Reprod Biol Endocrinol; 2023 Oct; 21(1):99. PubMed ID: 37891533
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive analyses indicated the association between m6A related long non-coding RNAs and various pathways in glioma.
Chen Z; Zhang W; Yan Z; Zhang M
Cancer Med; 2023 Jan; 12(1):760-788. PubMed ID: 35668574
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
6. An effective N6-methyladenosine-related long non-coding RNA prognostic signature for predicting the prognosis of patients with bladder cancer.
Ma T; Wang X; Meng L; Liu X; Wang J; Zhang W; Tian Z; Zhang Y
BMC Cancer; 2021 Nov; 21(1):1256. PubMed ID: 34802433
[TBL] [Abstract][Full Text] [Related]
7. IGF2BP2 promotes the progression of ovarian endometriosis by regulating m6A-modified MEIS2 and GATA6.
Zhao S; Zhang B; Yuan H; Yin Y; Qi S; Li W; Wu X; Yaling F
Int J Biochem Cell Biol; 2022 Nov; 152():106296. PubMed ID: 36113831
[TBL] [Abstract][Full Text] [Related]
8. Exploring diagnostic m6A regulators in endometriosis.
Jiang L; Zhang M; Wu J; Wang S; Yang X; Yi M; Zhang X; Fang X
Aging (Albany NY); 2020 Nov; 12(24):25916-25938. PubMed ID: 33232273
[TBL] [Abstract][Full Text] [Related]
9. METTL3-mediated m6A modification of SIRT1 mRNA inhibits progression of endometriosis by cellular senescence enhancing.
Wang X; Wang J; Zhao X; Wu H; Li J; Cheng Y; Guo Q; Cao X; Liang T; Sun L; Zhang G
J Transl Med; 2023 Jun; 21(1):407. PubMed ID: 37353804
[TBL] [Abstract][Full Text] [Related]
10. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients.
Xu S; Chen W; Wang Y; Zhang Y; Xia R; Shen J; Gong X; Liang Y; Xu J; Tang H; Zhao T; Zhang Y; Chen T; Wang C
BMC Cancer; 2022 Jul; 22(1):721. PubMed ID: 35778697
[TBL] [Abstract][Full Text] [Related]
11. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma.
Yang K; Wang F; Li K; Peng G; Yang H; Xu H; Xiang Y; Sun H
Technol Cancer Res Treat; 2022; 21():15330338221085354. PubMed ID: 35422168
[No Abstract] [Full Text] [Related]
12. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Analysis of N6-Methyladenosine-Related lncRNA Signature for Predicting Prognosis and Immune Cell Infiltration in Patients with Colorectal Cancer.
Zhao Z; Yang YB; Li XY; Li XG; Chu XD; Lin ZB; Zhang YR; Guo YG; Ding H; Pan YL; Wang L; Pan JH
Dis Markers; 2021; 2021():8686307. PubMed ID: 34745388
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B Virus X Protein Expression Is Tightly Regulated by N6-Methyladenosine Modification of Its mRNA.
Kim GW; Siddiqui A
J Virol; 2022 Feb; 96(4):e0165521. PubMed ID: 34851655
[TBL] [Abstract][Full Text] [Related]
15. N6-Methyladenosine-Related lncRNA Signature Predicts the Overall Survival of Colorectal Cancer Patients.
Song W; Ren J; Yuan W; Xiang R; Ge Y; Fu T
Genes (Basel); 2021 Aug; 12(9):. PubMed ID: 34573357
[TBL] [Abstract][Full Text] [Related]
16. Exploring the role of m6A methylation regulators in glioblastoma multiforme and their impact on the tumor immune microenvironment.
Deng X; Sun X; Hu Z; Wu Y; Zhou C; Sun J; Gao X; Huang Y
FASEB J; 2023 Sep; 37(9):e23155. PubMed ID: 37606566
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types.
Shen S; Zhang R; Jiang Y; Li Y; Lin L; Liu Z; Zhao Y; Shen H; Hu Z; Wei Y; Chen F
Mol Cancer; 2021 Apr; 20(1):67. PubMed ID: 33849552
[TBL] [Abstract][Full Text] [Related]
18. Identification of m6A methyltransferase-related lncRNA signature for predicting immunotherapy and prognosis in patients with hepatocellular carcinoma.
Li L; Xie R; Lu G
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34027555
[TBL] [Abstract][Full Text] [Related]
19. Analysis of N6-methyladenosine-related lncRNAs in the tumor immune microenvironment and their prognostic role in pancreatic cancer.
Liu Y; Wang T; Fang Z; Kong J; Liu J
J Cancer Res Clin Oncol; 2022 Jul; 148(7):1613-1626. PubMed ID: 35314871
[TBL] [Abstract][Full Text] [Related]
20. N6-methyladenosine (m6A)-connected lncRNAs are linked to survival and immune infiltration in glioma patients.
Wu WJ; Xiao F; Xiong Y; Sun GF; Guo Y; Zhou X; Hu GW; Huang K; Guo H
Biosci Rep; 2023 May; 43(5):. PubMed ID: 37083719
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
